KND Insider Trading Activity and SEC Form 4 Filings
KND insider trading summary
No open-market insider purchases or sales of Kindred Healthcare, Inc (KND) have been reported on SEC Form 4 in the past 12 months.
Latest KND insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 29, 2016 | John Joseph Lucchese | SVP & Chief Accounting Officer | Sell | $7K (605 @ $11.40) |
| Jun 29, 2016 | John Joseph Lucchese | SVP & Chief Accounting Officer | Sell | $29K (2,536 @ $11.39) |
| Jun 29, 2016 | John Joseph Lucchese | SVP & Chief Accounting Officer | Sell | $14K (1,200 @ $11.38) |
| Nov 10, 2015 | Paul J Diaz | Director | Buy | $627K (50,000 @ $12.53) |
| Aug 31, 2015 | Benjamin A Breier | President & CEO | Sell | $111K (5,400 @ $20.57) |
| Aug 21, 2015 | Jon B Rousseau | EVP, President, KRS | Sell | $164K (7,700 @ $21.36) |
| Aug 14, 2015 | Michael W Beal | President, Nursing Center Div | Sell | $54K (2,435 @ $22.31) |
| Jul 31, 2015 | Benjamin A Breier | President & CEO | Sell | $110K (5,400 @ $20.38) |
| Jun 30, 2015 | Benjamin A Breier | President & CEO | Sell | $110K (5,400 @ $20.32) |
| May 29, 2015 | Benjamin A Breier | President & CEO | Sell | $122K (5,400 @ $22.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.